Delivery Order SPE2DB22D1017-SPE2DB25FH0BL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,575.54 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on August 4, 2025, with completion targeted for August 5, 2025. This non-competitive, firm fixed-price delivery order represents a single transaction within AmerisourceBergen's larger federal pharmaceutical supply relationship. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,527.57 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injectors on August 1, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is scheduled for completion by August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 14, 2025. The contract is classified as firm fixed price with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a $2,807.37 delivery order to AmerisourceBergen Drug Corp for supply of Zepbound 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child purchase order under a larger contract vehicle supporting federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,184.50 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injectors on July 24, 2025, with completion expected by July 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was issued without set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,826.25 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $7,625.80. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by August 5, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.84 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside contract utilizing an existing contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $14,489.02 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injectors under a firm fixed price contract. The order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside transaction for pharmaceutical supply to support federal medical procurement needs. Performance of this delivery order is based at AmerisourceBergen's corporate office location in...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FH0BLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a ceiling value of $3,157.62. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a small-value pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the vendor to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare programs and the Defense Health Agency. As a major pharmaceutical distributor and critical vendor in the federal medical procurement landscape, AmerisourceBergen Drug Corp regularly fulfills delivery orders across multiple therapeutic domains through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/18/25 |